Search Results - "Çavdar, Eyyup"

The influence of visual objects and music on anxiety levels of breast cancer patients scheduled to experience chemotherapy for the first time: a prospective randomized clinical study by İriağaç, Yakup, Çavdar, Eyyüp, Karaboyun, Kubilay, Avci, Okan, Tuna, Nehir, Şeber, Erdoğan Selçuk

“…Objective To investigate the influence of music together with visual objects as an ambiance in the waiting room on anxiety levels of breast cancer patients…”
Get full text

Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer? by Demirci, Nebi Serkan, Çavdar, Eyyüp, Erdem, Gokmen Umut, Hatipoglu, Engin, Celik, Emir, Sezer, Sevilay, Yolcu, Ahmet, Dogan, Mutlu, Seber, Erdogan Selcuk

“…In the present study, we aimed to assess the association between the serum survivin level and overall survival and treatment response rates in metastatic…”
Get full text

Predictors of lymphovascular invasion in estrogen receptor positive/Her-2 negative breast cancer patients treated with neoadjuvant chemotherapy by Çavdar, Eyyüp, İriağaç, Yakup

“…Lymphovascular invasion (LVI) is considered a high-risk factor for recurrence in early-stage breast cancer, hence examination of LVI in pathological samples is…”
Get full text

Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function by Karaboyun, Kubilay, İriağaç, Yakup, Çavdar, Eyyüp, Avci, Okan, Şeber, Erdoğan S

“…Cisplatin-associated acute kidney injury is a common clinical event that causes increased morbidity and mortality in cancer patients even if they are…”
Get full text

The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy by Karaboyun, Kubilay, Çavdar, Eyyüp, İriağaç, Yakup, Yılmaz, Ahsen, Çelikkol, Aliye, Avcı, Okan, Şeber, Erdoğan Selçuk

“…Introduction: This study investigated the relationship between serum interleukin-20 (IL-20) levels and paclitaxel-associated neuropathy in patients with…”
Get full text

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study by Gursoy, Pınar, Tatli, Ali Murat, Erdem, Dilek, Goker, Erdem, Celik, Emir, Demirci, Nebi Serkan, Sakin, Abdullah, Atci, Muhammed Mustafa, Bayram, Ertuğrul, Telli, Tuğba Akın, Bilgin, Burak, Bilici, Ahmet, Akangunduz, Baran, Balli, Sevinç, Demirkazik, Ahmet, Selçukbiricik, Fatih, Menekse, Serkan, Cavdar, Eyyüp, Ozturk, Akın, Bekmez, Esma Türkmen, Turhal, Serdal, Kilickap, Sadettin, Yildirim, Hasan Çağrı, Oyan, Başak, Aksoy, Asude, Turkoz, Fatma Paksoy, Kut, Engin, Katgi, Nuran, Sakalar, Teoman, Akyol, Murat, Ellez, Halil İbrahim, Topcu, Atakan, Erdoğan, Atike Pınar, Pilanci, Kezban Nur, Hedem, Engin, Arak, Hacı, Akdeniz, Nadiye, Alan, Özkan, Yapar, Burcu, Nart, Deniz, Yumuk, Perran Fulden

“…Objectives To compare the survival of first- and second-generation tyrosine kinase inhibitors (TKIs) in patients with rare EGFR exon 18 and exon 20…”
Get full text

Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience by Demirci, Nebi Serkan, Cavdar, Eyyup, Ozdemir, Nuriye Yildirim, Yuksel, Sinemis, Iriagac, Yakup, Erdem, Gokmen Umut, Odabas, Hatice, Hacibekiroglu, Ilhan, Karaagac, Mustafa, Ucar, Mahmut, Ozturk, Banu, Bozkaya, Yakup

“…In ampullary cancer, 5-year survival rates are 30-50%, even with optimal resection and perioperative systemic therapies. We sought to determine the important…”
Get full text

Effects of COVID-19 Pandemic on Diagnosis-treatment Process in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy by ÇAVDAR, Eyyüp, İRİAĞAÇ, Yakup, KARABOYUN, Kubilay, AVCI, Okan, ŞEBER, Erdoğan Selçuk

“…Aim: In this study, we investigated the effect of pandemic on the diagnosis-treatment process in breast cancer patients receiving neoadjuvant chemotherapy…”
Get full text

Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study by Dülgar, Özgecan, Türker, Sema, Başaran, Gül, Araz, Murat, Sümbül, Ahmet Taner, Çağlayan, Dilek, Gümüşay, Özge, Biter, Sedat, Konca, Ahmet, Özen, Miraç, Demir, Hacer, Özdemir, Melek, Karataş, Fatih, Şahin, Elif, Çavdar, Eyyüp, Yasin, Ayşe İrem, Yaşar, Alper, Derin, Sümeyra, Pehlivan, Metin, Üyetürk, Ümmügül, Özdemir, Özlem, Kayıkçıoğlu, Erkan, Ak, Naziye, Şakalar, Teoman, Sakin, Abdullah, Büyükşimşek, Mahmut, Ay, Seval, Ertürk, İsmail, Akbaş, Sinem, Bir Yücel, Kadriye, Gümüş, Mahmut

“…We aimed to evaluate the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab plus…”
Get full text

Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T cell infiltration by Avci, Okan, Çavdar, Eyyup, İriağaç, Yakup, Karaboyun, Kubilay, Çelikkol, Aliye, Özçağlayan, Tuğba İlkem Kurtoğlu, Öznur, Meltem, Gürdal, Sibel Özkan, Şeber, Erdoğan Selçuk

“…Although early diagnosis of breast cancer (BC) is often associated with a good prognosis, there is currently no biomarker with high sensitivity serving this…”
Get full text

Use of Complementary Therapy in Lung Cancer Patients Treated with Chemotherapy and its Effect on Survival: A Cross-sectional Study by Cavdar, Eyyup, Karaboyun, Kubilay, Iriagac, Yakup, Avci, Okan, Seber, Erdogan Selcuk

“…Aim:Complementary therapies are being increasingly preferred in patients receiving anticancer therapy to strengthen the effect of chemotherapy and control…”
Get full text

Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study by Cavdar, Eyyup, Karaboyun, Kubilay, Iriagac, Yakup, Avci, Okan, Seber, Erdoğan Selcuk

“…Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer…”
Get full text

Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer by Çavdar, Eyyüp, İriağaç, Yakup, Sakin, Abdullah, Şeber, Erdoğan Selçuk

“…Objective: We aimed to investigate the factors affecting the complete response (CR) rate and the effect of treatment response on survival in patients with…”
Get full text

Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer by Iriagac, Yakup, Cavdar, Eyyup, Karaboyun, Kubilay, Avci, Okan, Alan, Ozkan, Taskaynatan, Halil, Celikkol, Aliye, Kara, Sonat Pinar, Erdal, Berna, Seber, Erdogan Selcuk

“…To compare seroconversion for SARS-CoV-2 receptor-binding domain (RBD) specific IgG positivity against two doses of the CoronaVac vaccine in breast and lung…”
Get full text

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group) by Erol, Cihan, Sakin, Abdullah, Başoğlu, Tuğba, Özden, Ercan, Çabuk, Devrim, Doğan, Mutlu, Öksüzoğlu, Berna, Yıldırım, Hasan Çağrı, Öner, İrem, Eryılmaz, Melek Karakurt, Dülgar, Özgecan, Aydın, Dinçer, Doğan, Neslihan, Özen, Miraç, Hacıbekiroğlu, İlhan, Özdemir, Nuriye, Gürler, Fatih, Paksoy, Nail, Karabulut, Senem, Aksoy, Asude, Hızal, Mutlu, Kahraman, Seda, Şen, Erdem, Paydaş, Semra, Çılbır, Ebru, Fırat, Feyza, Akdeniz, Nadiye, Özçelik, Melike, Oyman, Abdilkerim, Baytemür, Naziyet Köse, Acar, Ramazan, Almuradova, Elvina, Karabulut, Bülent, Şakalar, Teoman, Arak, Hacı, Değerli, Ezgi, Türker, Sema, Alan, Özkan, Er, Özlem, Taşçı, Elif Şenocak, Demir, Nazan, Çavdar, Eyyüp, Turhal, Serdar, Dede, Didem Şener, Akıncı, Muhammed Bülent, Yalçın, Bülent, Yumuk, Fulden, Yalçın, Şuayib, Şendur, Mehmet Ali Nahit

“…Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic…”
Get full text

Comprehensive analysis of the prognostic role of laboratory indices in advanced lung cancer patients by Cavdar, Eyyüp, Karaboyun, Kubilay, Kara, Kaan

“…Lung cancer, the most common cause of cancer-related death, is diagnosed mostly in advanced stages, and 5-year survival is approximately 5.8%. It is critical…”
Get full text

Comprehensive Analysis of Prognostic Factors in Advanced Gastric Cancer Patients Treated with Chemotherapy by Cavdar, Eyyup, Iriagac, Yakup, Avci, Okan, Seber, Erdogan Selcuk

“…Objective: To evaluate the strongest prognostic factors in advanced gastric cancer. Study Design: Observational study. Place and Duration of Study: Department…”
Get full text

Prognostic Significance of the Lymphocyte/Monocyte Ratio in Patients with Extensive Stage Small Cell Lung Cancer by Yakup İRİAĞAÇ, Eyyüp ÇAVDAR, Ahmet YOLCU

“…Purpose: Small cell lung cancer (SCLC) is a type of lung cancer that is sensitive to chemotherapy but has a poor prognosis. In this study, we aimed to…”
Get full text

Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy? by Karaboyun, Kubilay, Cavdar, Eyyup, Irıagac, Yakup, Celebı, Abdussamet, Kapagan, Tanju, Gulturk, Ilkay, Demır, Ozden, Avcı, Okan, Seber, Erdogan Selcuk

“…Aim The primary aim of this study was to compare tamoxifen versus aromatase inhibitors (AI) in terms of urinary incontinence (UI) in premenopausal female…”
Get full text

Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer by Cavdar, Eyyup, Iriagac, Yakup, Karaboyun, Kubilay, Avci, Okan, Seber, Erdoğan Selcuk

“…In older patients with cancer, it is very important to choose the appropriate treatment because they are at high risk for chemotherapy toxicity. Our study…”
Get full text